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Abstract
Background: Considering the recent popularity of bodybuilding and the apparent spread of anabolic androgenic
steroid (AAS) use amongst bodybuilding enthusiasts in Kuwait, there is a relative lack of scientific investigation into
the use, knowledge and attitudes towards AAS amongst the population at risk of abusing it. Therefore, this study
aims to investigate the frequency, knowledge, attitudes and practice of AAS use amongst male fitness centre
attendees in Kuwait.
Methods: A cross sectional survey utilizing a self-administered questionnaire was used. Information on demographics
as well as knowledge and attitude about and towards the use of AAS was included in the questionnaire. Ten fitness
centres in Kuwait were randomly selected and questionnaires were distributed to all individuals leaving each centre
on randomly selected days and periods of time for each centre. Overall n = 400 questionnaires were distributed.
Results: A total of n = 194 questionnaires were returned completed (~49 %). Of the responders, 22.7 % used AAS. The
19–25 age group had the highest occurrence (46.8 %) of first-time AAS use. In contrast with non-users, most (70.5 %)
of AAS users believed that having an optimally muscular body can only be achieved by using AAS, and a small
minority (6.8 %) believed that AAS usage would have significant harms to health. Only 18.2 % of AAS users had
appropriate knowledge regarding the side effects of AAS. Non-users were as much uninformed as AAS users
regarding the side effects of AAS.
Conclusion: The usage of AAS is high amongst male gym users in Kuwait and is likely to present an additional burden
to the health service. An effective initiative to minimize the burden of AAS abuse should focus on changing the
attitudes towards AAS rather than spreading awareness of their side effects.
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Background
Anabolic androgenic steroids (AAS) are synthetic deriva-
tives of testosterone having pronounced anabolic properties
and relatively weak androgenic properties [2]. They are
used clinically for the treatment of conditions characterized
by abnormally low production of testosterone, or muscle
wasting [4]. However, since the 1950s, AAS have been used
by professional body-builders and increasingly by young
adults to improve physical appearance [4, 20]. These non-
medical uses of AAS are associated with significant health
risks such as cardiovascular, hepatic, endocrine, psycho-
social and psychiatric disorders as well as death [8, 19].
Recently it has been reported that approximately 20 %
of athletes in the United States use AAS [7]. Life-time
prevalence of AAS across western countries is estimated
at between 1-6 % with the majority of users being male
[3]. Furthermore, the prevalence is estimated at ~38 %
amongst gym athletes [18]. Studies on prevalence rate in
the Middle East and North Africa (MENA) region are few,
and the prevalence rate is estimated at ~22 % amongst
gym users in the United Arab Emirates [1], and ~13 % of
Iranian youth training as body builders [12]. As regards
practice habits, a recent internet-based survey has re-
ported that the majority of users self-administer injectable
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AAS and reported subjective side-effects for AAS usage
(99.2 %); furthermore, 25 % of users are taking AAS,
growth hormone and insulin concurrently for anabolic
effects [13]. A study of Canadian college students showed
that AAS users were taking a variety of substance concur-
rently to enhance performance including caffeine, pain
killers, stimulants and beta-blockers [9].
Several studies have been conducted to assess the know-
ledge and attitude of people exercising in fitness centers
toward the use of AAS. A survey of ~5,000 men and
women in Denmark reported that AAS users have more
positive attitudes towards AAS use compared to non-
users across a variety of sports [15]. In Sweden, a survey
of ~4,000 male adolescents showed that fewer users
believed AAS to be harmful, while more believed that
females preferred males with bigger muscles. Moreover, it
showed that AAS users trained more often at gyms, drank
more alcohol and used narcotic drugs more often than
other male adolescents [11]. A survey of ~150 gym users
in the United Arab Emirates reported that 7 % of non-
users were planning future use of AAS [1]. In a recent
study in Kuwait, the prevalence of AAS users amongst
gym members was 11.8 %, and all of them started using
AAS when they were less than 20 years old [10].
Across the MENA region, the general public lack infor-
mation regarding the knowledge and attitudes of AAS
users. Considering the recent popularity of bodybuilding
and the apparent spread of Anabolic Androgenic Steroid
(AAS) use amongst bodybuilding enthusiasts in Kuwait,
there is relatively not enough scientific investigation into
the use, knowledge and attitudes towards AAS amongst
the population at risk of abusing it (namely; fitness centre’s
attendees). The aim of this study is to investigate the
knowledge, attitudes and practice of AAS use amongst
male fitness centres attendees in Kuwait.
Methods
Participants
This was a cross-sectional survey of males attending
fitness centres in Kuwait. These fitness centres were
randomly selected from the national telephone directory.
Self-administered questionnaires were then distributed to
all individuals leaving each centre on a randomly selected
day and period of time which was different for each
centre. Overall n = 400 questionnaires were distributed. A
total of n = 194 were returned completed (~49 %).
Measures/instruments
The survey questionnaire content and structure was
broadly based on that of [1], and included a sections on
demographics, as well as questions related to knowledge
and, attitudes about and towards use of AAS. Briefly, the
questionnaire consisted of 34 questions which were dis-
tributed as follows: demographics n = 3, AAS usage n = 4,
knowledge and attitude towards AAS n = 12, AAS prac-
tice habits n = 5, healthy lifestyle n = 7, and miscellan-
eous n = 3. Questions were closed type and answer
choices were a combination of Likert scale and tick-box
types. When a questionnaire was returned, it was
immediately checked for missing answers by the inves-
tigator and, if necessary, the participant was invited to
complete them accordingly. One question had a list of
11 undesirable effects, some associated with AAS use
and some unrelated to AAS, which was used to test the
knowledge about the side effects of AAS. The question
read, “adverse effects that can result from AAS use
include:” and the responder chose true, false, or don’t
know for each of the listed effects. Responders that
gave wrong responses or chose “don’t know” for more
than seven items in the list were assigned as having ‘inad-
equate knowledge’ about the potential harms. Responders
who gave correct answers for more than seven items in
the list were assigned as having ‘appropriate knowledge’.
The rest were assigned as having ‘some knowledge’.
Procedure
Ethical approval was obtained from the Ethics Committee
of Arabian Gulf University, Kingdom of Bahrain. Partici-
pation in the study was voluntary and all participants
signed a consent form prior to participating in the study.
Responses were confidential.
Statistical analysis
Statistical analysis was conducted using SPSS package
(version PASW Statistic 18.0.3). Chi-square test was
used to test for significant differences.
In our analysis, responders who’ve reported they hadn’t
used AAS (non-users) were divided into three groups
based on their intentions to use AAS in the future as
follows; 1) non-users who’ve reported they had intentions
to use AAS in the future (non-users with intentions to
use), 2) non-users who’ve reported they may or may not
use AAS in the future (non-users with undetermined
intentions), 3) non-users who’ve reported having no




The age distribution of the sample when divided into
users and non-users is shown in Table 1. There was a
statistically significant difference in age distribution
between users and non-users in our sample (Χ2 = 7.941,
df = 4, p < 0.05). The percentage of people who’ve used
AAS (“AAS users”) in our sample was 22.7 % (Fig. 1). In
this sample of responders, the age group at which AAS
were first used was 14–18 years (27.7 %); 19–25 years
(46.8 %); 26–34 years (17 %); >35 years (6.4 %). In our
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sample, 4.6 % of participants reported having primary
school education level, 23.7 % high school level of educa-
tion, 22.2 % Associate’s degree, and 49.5 % Bachelor
degree or higher. There was no statistically significant
difference in level of education between users and non-
users of AAS (Χ2 = 1.963, df = 3, p = 0.58).
Of the responders, 10.8 % were non-users with inten-
tions to use, 43.3 % were non-users with no intentions
to use, and 23.2 % were non-users with undetermined
intentions (Fig. 1).
Attitudes to AAS
A high percentage of users (70.5 %) and non-users with
intentions to use (67 %) agreed with the statement that
having an optimally muscular body can only be achieved
by using AAS; the difference between the two group was
not statistically significant (Χ2 = 0.61, df = 2, p = 0.737).
In contrast, a minority (19 %) of non-users with no inten-
tions to use agreed with that statement; which was signifi-
cantly less than AAS users (Χ2 = 35.014, df = 2, p < 0.0001)
as well as non-users with intentions to use (Χ2 = 19.451,
df = 2, p < 0.0001). Non-users with undetermined inten-
tions were much more divided in their attitudes regarding
the beneficial effects of AAS on muscular definition
(Table 2).
A small minority of AAS users (6.8 %) thought that
AAS usage is very harmful, 29.5 % thought that it is not
very harmful, and 56.8 % thought it is not harmful to
health if used correctly. Non-users with intentions to
use had the same distribution of attitude towards the
harmfulness of AAS (Χ2 = 1.507, df = 3, p = 0.68). In
contrast, 50 % of non-users with no intentions to use
reported that AAS usage is very harmful, 14.3 %
reported it is not very harmful, and 19 % reported it is
not harmful if used correctly; this distribution is signifi-
cantly different from that of the aforementioned two
groups of participants (Χ2 = 33.727, df = 3, p < 0.000001,
Χ2 = 19.092, df = 3, p < 0.001, respectively) (Table 2).
Peer effect
Nearly all AAS users (97.8 %) and most non-users with
intentions to use (90.5 %) personally knew someone who
was using AAS, with no statistically significant difference
in the percentage between the two groups (Χ2 = 1.698, df
= 1, p = 0.19). The percentage, however, was significantly
less (80 %) amongst non-users with undetermined inten-
tions compared to AAS users (Χ2 = 7.01, df = 1, p < .01).
On the other hand, only 64.3 % of non-users with no
intentions to use knew an AAS user, which is significantly
less than the percentage amongst AAS users (Χ2 = 17.595,
df = 1, p <0 .0001) (Table 2).
Reported reasons for not using AAS
Several reasons for not using AAS were reported. When
analyzed, being harmful to health was the most important
single reason for not using AAS, and having not felt the
need to use AAS was the second. Amongst non-users with
no intentions to use (n = 84); only 58.3 % reported that
being harmful to health was their primary reason for not
using AAS, and 27.4 % reported that it was not their
reason at all. Amongst the non-users with no intentions
to use and non-users with undetermined intentions
combined (n = 129), only 34.1 % reported that being
harmful to health is their primary reason for not using
AAS, and 49.4 % reported it was not their reason at all.
Motivation to exercise
A total of 81.8 % of AAS users and 71.4 % of non-users
with intentions to use reported that getting muscular
body appearance was their primary reason for attending
the fitness centre. Amongst non-users with no intentions
Table 1 Age distribution of users and non-users of Anabolic
Androgenic Steroids
Age (years) 14 – 19 20 – 29 30 – 40 >40 Total
(number)
AAS users 9 % (4) 56.8 % (25) 25 % (11) 9 % (4) 44
Non-users 22 % (33) 59.3 % (89) 16 % (24) 2.6 % (4) 150
Total 19 % (37) 58.8 % (114) 18 % (35) 4 % (8) 194
Fig. 1 Distribution of participants based on history and intention of using Anabolic Androgenic Steroids
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to use, 39.3 % reported that getting muscular body
appearance was their primary reason for attending the
fitness centre, which was significantly different from
AAS users (Χ2 = 21.022, df = 1, p <0.0001).
Practice of AAS use
Both oral and injectable forms of AAS were used in
approximately equal frequency, and a combination of
oral and injectable AAS was the most common practice
(42.6 %) (Fig. 2). Furthermore, 53.2 % administered one
or more courses of AAS consisting of a combination
of ≥ 2 substances.
Usage of other substances
The frequency of intake of many (≥3) other ergogenic aids
and supplements (e.g. growth hormone, Nitric Oxide-
containing supplements, creatine-containing supplements,
etc.) was highest amongst AAS users (80 %), and was
significantly higher than amongst non-users with intentions
to use (28.6 %) as well as the prevalence amongst all non-
users (17.3 %) (Χ2 = 15.859, df = 1 p < 0.0001, Χ2 = 61.082,
df = 1 p <0.0001, respectively) (Table 2). The frequency of
smoking was significantly higher (70.5 %) in AAS users
than (48.7 %) in non-users (Χ2 = 6.296, df = 1 p < 0.05).
Source of AAS
Users obtained AAS from a variety of sources as follows:
gym coach (62.1 %), individual supplier (58.8 %), whilst
travelling abroad (34.6 %), pharmacy or physician
(30.8 %), internet order (25.9 %) and friends (24 %).
Knowledge
Fifty nine percent of AAS users and 24.7 % of non-users
reported that they believed they have enough informa-
tion regarding AAS. When the knowledge about poten-
tial adverse effects of AAS was examined, we found that
50 % of users had inadequate knowledge and only
18.2 % of them had appropriate knowledge. There was
no significant difference between users and non-users in
knowledge of side effects (Χ2 = 0.561, df = 2, p = 0.75).
Discussion
This study investigated the frequency, knowledge, attitudes
and practice of AAS use in Kuwait amongst male fitness
centre attendees. The frequency of AAS users was 22.7 %,
which is higher than what was reported in a similar study
in Kuwait (11.8 %) [10] and what was previously reported
amongst Iranian youth training as body builders (~13 %)
[12], but less than previously reported for gym athletes
(~38 %) [18], and similar to that reported amongst gym
users in the United Arab Emirates (~22 %) [1]. Highest fre-
quency of first time AAS usage was in the age group 19–25
years (46.8 %). This finding is somewhat similar to that
Table 2 Differences amongst participants based on history and intention of using Anabolic Androgenic Steroids
Variable AAS users Non-user
With intentions to use With undetermined intentions With no intentions to use
Having an optimally muscular body can only be achieved by using AAS
True 70.5 % 67 % 34 % 19 %
False 25 % 24 % 36 % 51 %
I don’t know 4.5 % 9 % 30 % 30 %
Do you personally know an AAS user?
Yes 99.78 % 90.5 % 80 % 64.3 %
Is AAS harmful?
Yes, very harmful 6.8 % 9.5 % 20 % 50 %
Not very harmful 29.5 % 42.9 % 33.3 % 14.3 %
No, not if it was used correctly 56.8 % 42.9 % 24.4 % 19 %
I don’t know 6.8 % 4.8 % 22.2 % 16.7 %
Use many (>3) supplements and aids to achieve his goals in the gym (other than AAS)
Does 80 % 28.6 % 24.4 % 10.7 %
Fig. 2 Route of administration of Anabolic Androgenic Steroids
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reported by others in the MENA region [1, 10, 17];
however, in Sweden age of first usage is lower (16–17
years) [16].
Considering that AAS users were as educated as non-
users, it does not appear that the level of education was
a factor in the decision to use AAS in this study. Both
the belief that AAS are crucial to optimum muscular
bulk, and personally knowing someone who uses AAS,
were associated with AAS use. AAS users and non-
users with intentions to use believed more strongly in
the benefits of AAS and were less worried about the
risks associated with their use. Overall, users perceived
that the benefits to muscle bulk outweighed the risks of
negative side-effects. These findings are in broad agree-
ment with those reported in other studies of gym users
and athletes [1, 10, 14, 15].
It is interesting that only 34.1 % of non-users (excluding
non-user with intentions to use) reported that being
harmful to health was their primary reason for not using
AAS. Most of non-users with no intentions to use AAS
have joined the gym for reasons other than body-building,
and most of them reported they have not felt the need to
use AAS to achieve their desired goal in the gym. This
indicate that the main reason gym members did not use
AAS was that they didn’t think or feel they needed them,
and not because of their side effects. This piece of infor-
mation could be crucial for any effort toward controlling
the spread of AAS abuse.
The use of AAS was linked with the use of other
subsances; AAS usage was clearly associated with a much
higher frequency of intake of many (≥3) ergogenic aids
and other substances (e.g. growth hormone, Nitric Oxide-
containing supplements, creatine-containing supplements,
etc.), and a higher frequency of smoking. These results are
in agreement with those reported by previous studies
[2, 3, 9, 11, 13].
Fifty nine percent of users reported believing they have
enough information regarding AAS. However, 50 % of
user had no or incorrect information and only 18.2 % of
them had appropriate knowledge regarding the potential
adverse effect of AAS use. Deficient knowledge about
complications of AAS was also reported in previous
studies [12]. Interestingly, non-users were as much
uninformed as users about the side effects of AAS, even
though a significantly larger percentage of them thought
they are harmful to health. Supporting the conclusion that
spreading awareness about the side effects of AAS may
not be the most effective strategy for limiting their abuse.
These results show that the attitudes towards AAS do not
correspond with knowledge about their harms, and the
attitudes towards AAS are more strongly associated with
their use than is knowledge of the potential harms.
The reported main source for acquiring AAS was gym
coaches (62.1 %), and this is similar to that previously
reported by previous studies [1, 10]. Furthermore, it is of
concern that even though AAS are illegal in Kuwait, a
significant percentage of users (30.8 %) reported being
able to acquire AAS from pharmacists and physicians
who are knowledgeable regarding the risks of taking
AAS. This is all the more significant because oral route
of administration was common (which is more hepato-
toxic), with 53.2 % administering ≥1 courses of AAS
combining ≥ 2 substances; and that is a high usage rate
that increases the risk of side-effects. This may present
an additional burden to the health service by a relatively
young group of adults. From a regulatory perspective,
there may be a need to consider tightening the control
of distribution of AAS.
The main limitation of this study was that participants
were self-selected insofar as 51.5 % (i.e. n = 206) of fitness
centre attendees failed to return the completed question-
naire. When asked about the reason for not completing
the questionnaire virtually all of them replied that they felt
it was too long. However, there was no feedback that
indicated preferential participation by users compared to
non-users or vice versa. Furthermore, the age was given as
age brackets, therefore the means and standard deviations
could not be calculated. On the other hand, the main
strength of this study is that, in the analyses, it factors in
the intentions to use AAS in the future at the point when
the data was collected. This gives more accurate picture of
the relationship between AAS use and other parameters.
Conclusion
The study concludes that the beliefs and attitudes regard-
ing the effects of AAS on muscle and the harmfulness of
AAS are significantly different between users and non-
users, this is expected and was already established in the
previous studies. However, this study also shows that the
presence of intentions to use AAS is associated with
attitudes similar to those of AAS users, this suggests that
the attitude precedes and anticipates, and therefore is the
cause and not the result of, the decision to use AAS.
From our results, it appears that knowledge or ignor-
ance about the potential harms of AAS is not a major
factor influencing the use of AAS. The magnitude of
concerns about the actual likelihood and the severity of
the side effects of AAS are rather far more influential.
However, the main factor determining one’s decision to
use AAS is the perceived need for AAS to reach one’s
goals in the gym. In other words, the factors that leads an
individual to use or not use AAS are mainly whether or
not that person wants to build bulky muscles, and
whether or not he believes AAS are crucial for that
purpose. Moreover, peer effect appears to be strikingly
important in the misuse of AAS. Given that smoking,
as well as the use of multiple substances that are gener-
ally considered to be a risk to health, are more frequent
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amongst AAS users, it is reasonable to suggest that a
personality that is associated with addictions or risk
taking behaviour may also be associated with AAS use.
The results of this study lead us towards a different
conclusion from what was intuitively assumed and
usually expected, and from what was recommended in
some previous studies. Namely, education regarding the
side effects of AAS is not the crucial area to address
when effectively decreasing the abuse of AAS is desired.
This, however, agrees with the conclusions of some
previous publications [5, 6].
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
IA came up with the research question, researched the literature, designed
the methodology, participated in the distribution and collection of the
survey, entered the data, did the statistical analysis, interpreted the results,
and wrote most of the paper. JRA reviewed the literature and assisted in
interpreting the results and constructing the tables and graphs. Both authors
read and approved the final manuscript.
Acknowledgements
We would like to thank the following: Ahmad M Alshammari, M.D., for his
contribution in editing the grammar and language of the manuscript.
Abbas Johar, Ali Alfaras, Ali Maradashti, and Mishari AlNaqi for assisting in the
distribution of the survey and in data entry.
Received: 16 February 2015 Accepted: 17 August 2015
References
1. Al-falasi, O., Al-dahmani, K., Al-eisaei, K., Al-ameri, S., Al-maskari, F.,
Nagelkerke, N., & Schneider, J. (2008). Knowledge, attitude and practice of
anabolic steroids use among gym users in Al-Ain District, United Arab
Emirates, 75–81. http://benthamopen.com/ABSTRACT/TOSMJ-2-75.
2. Bahrke MS, Yesalis CE, Brower KJ. Anabolic-androgenic steroid abuse and
performance-enhancing drugs among adolescents. Child Adolesc Psychiatr
Clin N Am. 1998;7(4):821–38. Retrieved from http://www.ncbi.nlm.nih.gov/
pubmed/9894044.
3. Baker JS, Graham MR, Davies B. Steroid and prescription medicine abuse in
the health and fitness community: a regional study. Eur J Intern Med.
2006;17(7):479–84. doi:10.1016/j.ejim.2006.04.010.
4. Fitness, C. on S. M. and (1997). Adolescents and Anabolic Steroids: A Subject
Review. Pediatrics, 99 (6), 904–908. doi:10.1542/peds.99.6.904. http://
pediatrics.aappublications.org/content/99/6/904.full.
5. Goldberg L, Bents R, Bosworth E, Trevisan L, Elliot DL. Anabolic steroid
education and adolescents: do scare tactics work? Pediatrics. 1991;87:283–6.
6. Goldberg L, Goldberg L, Elliot D, Clarke GN, MacKinnon DP, Moe E, et al.
Effects of a multidimensional anabolic steroid prevention intervention. The
Adolescents Training and Learning to Avoid Steroids (ATLAS) Program.
JAMA. 1996;276:1555–62. doi:10.1001/jama.276.19.1555.
7. Hall RCW, Hall RCW. Abuse of supraphysiologic doses of anabolic steroids.
South Med J. 2005;98:550–5. doi:10.1097/01.SMJ.0000157531.04472.B2.
8. Kious BM. Philosophy on steroids: why the anti-doping position could use a
little enhancement. Theor Med Bioeth. 2008;29:213–34.
doi:10.1007/s11017-008-9078-9.
9. Melia P, Pipe A, Greenberg L. The use of anabolic-androgenic steroids by
Canadian students. Clin J Sport Med. 1996;6(1):9–14.
doi:10.1097/00042752-199601000-00004.
10. Mohammad H. Anabolic-androgenic steroids amongst Kuwaiti males. Coll
Stud J. 2014;48(1):120–9. Retrieved from https://www.questia.com/library/
journal/1G1-372252074/anabolic-androgenic-steroids-amongst-kuwaiti-
males.
11. Nilsson S, Spak F, Marklund B, Baigi A, Allebeck P. Attitudes and behaviors
with regards to androgenic anabolic steroids among male adolescents in a
county of Sweden. Subst Use Misuse. 2004;39(8):1183–97.
doi:10.1081/JA-120030060.
12. Nojoomi, M., & Behravan, V. (2005). Study of anabolic steroids and the awareness
of their complications in bodybuilding athletes in Karaj (2003). RJMS. Retrieved
from http://rjms.iums.ac.ir/browse.php?a_code=A-10-1-134&slc_lang=en&sid=1.
13. Parkinson AB, Evans NA. Anabolic androgenic steroids: a survey of 500 users.
Med Sci Sports Exerc. 2006;38(4):644–51. doi:10.1249/
01.mss.0000210194.56834.5d.
14. Santos AM, da Rocha MSP, da Silva MF. Illicit use and abuse of
anabolic-androgenic steroids among Brazilian bodybuilders. Subst Use
Misuse. 2011;46(6):742–8. doi:10.3109/10826084.2010.534123.
15. Singhammer J. (2013). Attitudes toward anabolic-androgenic steroids
among non-competing athletes in various types of sports – a
cross-sectional study –. sport science review, XXII(1–2), 109–128.
doi:10.2478/ssr-2013-0006.
16. Nilsson S, Marklund B, Fridlund B. Trends in the misuse of androgenic
anabolic steroids among boys 16?17 years old in a primary health care area
in Sweden. Scand J Prim Health Care. 2001;19(3):181–2.
doi:10.1080/028134301316982423.
17. Tahtamouni LH, Mustafa NH, Alfaouri AA, Hassan IM, Abdalla MY, Yasin SR.
Prevalence and risk factors for anabolic-androgenic steroid abuse among
Jordanian collegiate students and athletes. Eur J Public Health.
2008;18(6):661–5. doi:10.1093/eurpub/ckn062.
18. Thiblin I, Petersson A. Pharmacoepidemiology of anabolic androgenic
steroids: a review. Fundam Clin Pharmacol. 2005;19(1):27–44.
doi:10.1111/j.1472-8206.2004.00298.x.
19. Van Amsterdam J, Opperhuizen A, Hartgens F. Adverse health effects of
anabolic-androgenic steroids. Regul Toxicol Pharmacol. 2010;57:117–23.
doi:10.1016/j.yrtph.2010.02.001.
20. Wilson JD. Androgen abuse by athletes. Endocr Rev. 1988;9:181–99.
doi:10.1210/edrv-9-2-181.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Alsaeed and Alabkal Substance Abuse Treatment, Prevention, and Policy  (2015) 10:33 Page 6 of 6
